5 Cases of Ocean County Measles Outbreak

The New Jersey Department of Health is warning residents that 5 additional cases of measles — a highly contagious disease — have been confirmed in Ocean County. This brings the total to 11 confirmed cases. These individuals could have exposed others to the infection while in Ocean County on November 1.

Anyone who visited the following locations may have been exposed to measles:

Office of Dr. Eli Eilenberg, 150 James St, Lakewood, NJ 08701
- November 1 between 12:00 p.m. and 4:30 p.m.

The Department is working in collaboration with the Ocean County Health Department to identify and notify people who might have been exposed during the time the individuals were infectious. For a comprehensive list of exposures identified to date related to this outbreak, please visit the Department’s measles page.

Continue reading →

Deadly Adenovirus Outbreak Infects Four More Kids

Lab testing over the weekend confirmed that four more children have been infected by adenovirus at the Wanaque Center, a pediatric long-term care facility in Passaic County. The state Health Department confirmed Monday that the viral outbreak has killed ten young patients. So far 33 patients have been infected, as well as one adult who works there. The first case of the virus was reported Sept. 26, and the most recent was on Friday, Nov. 9th. (NJ Advance Media)

Continue reading →

Comments

AMP wordcloud

The National Institutes of Health is teaming with government, biopharmaceutical, life science and non-profit organizations to overcome obstacles and increase success for advancing promising treatments for Parkinson’s disease (PD). Part of the NIH Accelerating Medicines Partnership (AMP), AMP PD will focus on identifying and validating promising markers of disease called biomarkers that may be useful in tracking the progression of PD and could serve as biological targets for the development of new drugs.

“Advancing treatments for Parkinson’s disease is hampered by insufficient understanding of biological networks; drugs aimed at seemingly promising therapeutic targets fail in clinical trials,” said NIH Director Francis S. Collins, M.D., Ph.D. “By combining our expertise and resources, AMP PD partners hope to increase our collective odds of success in accelerating the development of effective treatments for a million Americans who suffer from this debilitating disease.”